chr12-2053574-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_000719.7(CACNA1C):āc.12G>Cā(p.Glu4Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,448,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 31)
Exomes š: 0.0000014 ( 0 hom. )
Consequence
CACNA1C
NM_000719.7 missense
NM_000719.7 missense
Scores
4
5
8
Clinical Significance
Conservation
PhyloP100: 1.63
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1C. . Gene score misZ 6.4654 (greater than the threshold 3.09). Trascript score misZ 7.2674 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, Brugada syndrome, long QT syndrome, short QT syndrome, long qt syndrome 8, Timothy syndrome, Brugada syndrome 3.
BP4
Computational evidence support a benign effect (MetaRNN=0.2046144).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000406454.8 | c.12G>C | p.Glu4Asp | missense_variant | 1/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000347598.9 | c.12G>C | p.Glu4Asp | missense_variant | 1/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.12G>C | p.Glu4Asp | missense_variant | 1/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.12G>C | p.Glu4Asp | missense_variant | 1/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000399638.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.12G>C | p.Glu4Asp | missense_variant | 1/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.12G>C | p.Glu4Asp | missense_variant | 1/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.12G>C | p.Glu4Asp | missense_variant | 1/46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000682544.1 | c.140-61650G>C | intron_variant | ENSP00000507184.1 | ||||||
CACNA1C | ENST00000683824.1 | c.140-61650G>C | intron_variant | ENSP00000507867.1 | ||||||
CACNA1C | ENST00000682462.1 | c.140-61650G>C | intron_variant | ENSP00000507105.1 | ||||||
CACNA1C | ENST00000683781.1 | c.140-61650G>C | intron_variant | ENSP00000507434.1 | ||||||
CACNA1C | ENST00000683840.1 | c.140-61650G>C | intron_variant | ENSP00000507612.1 | ||||||
CACNA1C | ENST00000683956.1 | c.140-61650G>C | intron_variant | ENSP00000506882.1 | ||||||
CACNA1C | ENST00000480911.6 | n.12G>C | non_coding_transcript_exon_variant | 1/27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1448312Hom.: 0 Cov.: 32 AF XY: 0.00000139 AC XY: 1AN XY: 719044
GnomAD4 exome
AF:
AC:
2
AN:
1448312
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
719044
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 4 of the CACNA1C protein (p.Glu4Asp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1C protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;N;.;N;N;N;N;N;N;N;N;N;N;N;N;N;.;N;N;N;.;.;.
MutationTaster
Benign
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;T;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
0.93, 0.43, 0.59, 0.53, 0.27
.;P;.;B;P;P;P;P;P;P;P;P;B;P;P;P;.;P;P;.;.;.;.
Vest4
MutPred
Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);Gain of catalytic residue at R7 (P = 0.1002);
MVP
MPC
2.1
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at